P. Braitstein, M. Brinkhof, F. Dabis, M. Schechter, A. Boulle et al., Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries, Lancet, vol.367, issue.9513, pp.817-841, 2006.

S. Kippax, P. Aggleton, J. Moatti, and J. Delfraissy, Living with HIV: Recent research from France and the French Caribbean (VESPA study), Australia, Canada and the United Kingdom, AIDS, vol.21, issue.Suppl 1, pp.1-3, 2007.
DOI : 10.1097/01.aids.0000255078.01234.71

P. Peretti-watel, B. Spire, Y. Obadia, and J. Moatti, Discrimination against HIV-Infected People and the Spread of HIV: Some Evidence from France, PLoS ONE, vol.92, issue.3, p.411, 2007.
DOI : 10.1371/journal.pone.0000411.t001

B. Spire, S. Duran, M. Souville, C. Leport, F. Raffi et al., Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach, Social Science & Medicine, vol.54, issue.10, pp.1481-96, 2002.
DOI : 10.1016/S0277-9536(01)00125-3

J. Ware and C. Sherbourne, The MOS 36-ltem Short-Form Health Survey (SF-36), Medical Care, vol.30, issue.6, pp.473-83, 1992.
DOI : 10.1097/00005650-199206000-00002

A. Wu, D. Revicki, D. Jacobson, and F. Malitz, Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV) Qual Life Res, pp.481-93, 1997.

A. Justice, W. Holmes, A. Gifford, L. Rabeneck, R. Zackin et al., Development and validation of a self-completed HIV symptom index, Journal of Clinical Epidemiology, vol.54, issue.12, pp.77-90, 2001.
DOI : 10.1016/S0895-4356(01)00449-8

S. Duran, B. Spire, F. Raffi, V. Walter, D. Bouhour et al., Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAART, HIV Clinical Trials, vol.4, issue.9, pp.38-45, 2001.
DOI : 10.1097/00002030-199909100-00022

F. Marcellin, S. Boyer, C. Protopopescu, A. Dia, P. Ongolo-zogo et al., Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaounde, Cameroon (EVAL survey, ANRS 12-116) Trop Med Int Health, pp.1470-1478, 2008.

B. Spire, F. Marcellin, I. Cohen-codar, P. Flandre, F. Boue et al., Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trial, Antivir Ther, vol.13, issue.4, pp.591-600, 2008.

A. Ammassari, R. Murri, P. Pezzotti, M. Trotta, L. Ravasio et al., Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.28, issue.5, pp.445-454, 2001.
DOI : 10.1097/00042560-200112150-00006

E. Vincent, A. Bouhnik, M. Carrieri, D. Rey, P. Dujardin et al., Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users, AIDS, vol.18, issue.9, pp.1321-1326, 2004.
DOI : 10.1097/00002030-200406180-00011

C. Protopopescu, F. Marcellin, M. Preau, D. Gabillard, R. Moh et al., Psychosocial correlates of inconsistent condom use among HIV-infected patients 6

D. Castro, N. Braun, J. Charreau, I. Pialoux, G. Cotte et al., Switch from Enfuvirtide to Raltegravir in Highly Treatment-experienced HIV-1-infected Patients: A Randomized Open-label Non-inferiority Trial, Easier ANRS 138 Abstract 572. The 16th conference on retroviruses and opportunistic infections United Nations program on HIV/AIDS; 2009. 16. WHO. Rapid advice: Antiretroviral therapy for HIV infection in adults and adolescents, 15. UNAIDS. AIDS epidemic update, 2009.

R. Becquet, D. Ekouevi, E. Arrive, J. Stringer, N. Meda et al., Universal antiretroviral therapy for pregnant and breast-feeding HIV-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings WHO. Rapid advice: Recommendations for Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model, Clin Infect Dis. Lancet, vol.49373, issue.189657, pp.1936-4548, 2009.

F. Marcellin, C. Bonono, J. Blanche, M. Carrieri, B. Spire et al., Higher risk of unsafe sex and impaired quality of life among patients not receiving antiretroviral therapy in Cameroon: results from the EVAL survey (ANRS 12???116), AIDS, vol.24, issue.Suppl 1, 2010.
DOI : 10.1097/01.aids.0000366079.83568.a2